Consolidated Statements of Changes to Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Cumulative Effect Period of Adoption Adjusted Balance [Member]	Common Stock [Member]	Common Stock [Member] Cumulative Effect Period of Adoption Adjusted Balance [Member]	Treasury Stock [Member]	Treasury Stock [Member] Cumulative Effect Period of Adoption Adjusted Balance [Member]	Retained Earnings [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member] Cumulative Effect Period of Adoption Adjusted Balance [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Other Comprehensive Income (Loss) [Member] Cumulative Effect Period of Adoption Adjusted Balance [Member]
Beginning balance at Dec. 31, 2020	$ 249,160			$ 81,804		$ (11,932)		$ 173,591			$ 5,697
Beginning balance, shares at Dec. 31, 2020				11,197,544
Net income	23,495							23,495
Other comprehensive income (loss)	(8,881)										(8,881)
Issuance of common stock in acquisition	41,078			$ 41,078
Issuance of common stock in acquisition, shares				1,833,845
Purchase of treasury stock	(338)					(338)
Purchase of treasury stock, shares				(14,611)
Issuance of restricted stock (Net of forfeitures)				$ (1,030)		507		523
Issuance of restricted stock (Net of forfeitures), Shares				46,175
Stock-based compensation expense	822			$ 822
Director stock awards	73					39		34
Director stock awards, shares				3,280
Cash dividends declared	(8,242)							(8,242)
Ending balance at Dec. 31, 2021	297,167			$ 122,674		(11,724)		189,401			(3,184)
Ending balance, shares at Dec. 31, 2021				13,066,233
Net income	32,515							32,515
Other comprehensive income (loss)	(35,049)										(35,049)
Issuance of common stock in acquisition, shares				500,426
Issuance of common stock in acquisition, net off repurchases	13,443			$ 13,446		(3)
Issuance of common stock in acquisition, net off repurchases, shares				500,301
Purchase of treasury stock	(308)					(308)
Purchase of treasury stock, shares				(9,488)
Issuance of restricted stock (Net of forfeitures)				$ (1,522)		428		1,094
Issuance of restricted stock (Net of forfeitures), Shares				48,496
Stock-based compensation expense	899			$ 899
Director stock awards	120					34		86
Director stock awards, shares				2,880
Cash dividends declared	(10,647)							(10,647)
Ending balance at Dec. 31, 2022	298,140	$ (3,371)	$ 294,769	$ 135,497	$ 135,497	(11,573)	$ (11,573)	212,449	$ (3,371)	$ 209,078	(38,233)	$ (38,233)
Ending balance, shares at Dec. 31, 2022				13,608,422	13,608,422
Net income	22,787							22,787
Other comprehensive income (loss)	9,221										9,221
Purchase of treasury stock	(218)					(218)
Purchase of treasury stock, shares				(10,704)
Issuance of restricted stock (Net of forfeitures)				$ (1,263)		641		622
Issuance of restricted stock (Net of forfeitures), Shares				57,875
Stock-based compensation expense	1,281			$ 1,281
Director stock awards	180					110		70
Director stock awards, shares				9,048
Cash dividends declared	(11,477)							(11,477)
Ending balance at Dec. 31, 2023	$ 316,543			$ 135,515		$ (11,040)		$ 221,080			$ (29,012)
Ending balance, shares at Dec. 31, 2023				13,664,641